Stockscreener 앱 받기
108.08
1.10%
-1.20
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
GeneDx (NASDAQ:WGS) Shares Up 7.9%Should You Buy? - MarketBeat
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
What makes GeneDx Holdings Corp stock attractive todayJuly 2025 Sentiment & Technical Pattern Based Buy Signals - baoquankhu1.vn
MACD Signal: Is GeneDx Holdings Corp stock forming a triangle patternQuarterly Market Summary & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum - Seeking Alpha
GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears - TechStock²
GeneDx (NASDAQ:WGS) Trading Down 8.9%Time to Sell? - MarketBeat
CEO Change: Can GeneDx Holdings Corp Equity Warrant continue delivering strong returnsRate Cut & Long Hold Capital Preservation Tips - baoquankhu1.vn
RSI Check: Is GeneDx Holdings Corp. Equity Warrant stock positioned well for digital economyJuly 2025 Pullbacks & High Conviction Investment Ideas - Bộ Nội Vụ
Cathie Wood Sells Meta and Illumina, Loads Up on Early-Stage Genomics Stocks - Blockonomi
Cathie Wood Dumps Meta, Loads Up on Beaten-Down GeneDx Stock - CoinCentral
GeneDx expects 2026 revenue between $540-555 million amid growth By Investing.com - Investing.com Nigeria
Aug Update: What are the risks of holding GeneDx Holdings CorpNew Guidance & Capital Protection Trading Alerts - baoquankhu1.vn
Market Pulse: What is the Moat Score of GeneDx Holdings Corp2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
GeneDx Reports Strong 2025 Results and 2026 Growth Outlook - TipRanks
GeneDx (NASDAQ:WGS) Shares Gap DownHere's Why - MarketBeat
GeneDx (WGS) stock dives on 2026 guidance despite strong 2025 prelims — what to watch next - TechStock²
GeneDx stock falls after 2026 guidance disappoints investors By Investing.com - Investing.com Canada
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance - BioSpace
GeneDx Partners With Komodo Health to Advance Rare Disease Research - Yahoo Finance
Genedx shares down 2.5% after announcing preliminary Q4 results, 2026 outlook - marketscreener.com
GeneDx expects 2026 revenue between $540-555 million amid growth - Investing.com
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - MSN
Peregrine Capital Management LLC Has $8 Million Stock Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
Why GeneDx Holdings Corp. stock could rally in 2025Swing Trade & Smart Money Movement Tracker - Улправда
Why GeneDx Holdings Corp. Equity Warrant stock is rated strong buyJuly 2025 Review & Stepwise Trade Signal Guides - Улправда
How GeneDx Holdings Corp. stock trades during market volatilityMarket Activity Summary & Reliable Price Breakout Signals - Улправда
Is GeneDx Holdings Corp. Equity Warrant stock positioned for digital transformation2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - Улправда
GeneDx partners with Komodo Health to create comprehensive rare disease dataset - Investing.com Canada
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset - Business Wire
Is GeneDx Holdings (WGS) Pricing Look Attractive After Mixed Long Term Share Performance - Yahoo Finance
Published on: 2026-01-13 07:12:59 - ulpravda.ru
GeneDx Announces GenomeDx Prenatal, Expanding Genomic Diagnosis into Prenatal Care - marketscreener.com
GeneDx to launch whole genome sequencing test for fetal anomalies By Investing.com - Investing.com Canada
New prenatal genome test offers faster answers after troubling ultrasounds - Stock Titan
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care - Business Wire
A Look At GeneDx Holdings (WGS) Valuation After New CMO Appointment And Record Rare Disease Genomics Year - Yahoo Finance
GeneDx appoints Dr. Linda Genen as CMO - MSN
GeneDx Holdings Corp.Class A Common Stock (NQ: WGS - FinancialContent
GeneDx appoints Linda Genen as chief medical officer By Investing.com - Investing.com Australia
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care - marketscreener.com
Should GeneDx’s GUARDIAN Newborn Genomics Accolade Reshape the Investment Narrative for WGS Investors? - simplywall.st
Genomic newborn screening may find serious diseases traditional tests miss - Stock Titan
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025 - Business Wire
(WGS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - MSN
What Do Analysts Think About GeneDx Holdings Corp. (WGS)? - Insider Monkey
Simplify Asset Management Inc. Sells 41,071 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference - marketscreener.com
Ajooni Biotech Limited Uptrend in Early Stages Indicators Say YesVolatility Index Analysis & You’ve Never Seen Stock Picks Like These - earlytimes.in
GeneDx Holdings Corp. $WGS Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Assenagon Asset Management S.A. Has $1.52 Million Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat
Behavioral Patterns of WGS and Institutional Flows - Stock Traders Daily
What analysts say about GeneDx Holdings Corp Equity Warrant stockReal Estate Investment Trusts & Rapid Portfolio Appreciation - earlytimes.in
2.51%
0.74%
자본화:
|
볼륨(24시간):